Review articlePublished 30 Dec 2011
Tumour Hypoxia and Prostate Cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hypoxia is a known hallmark of endocrine tumours including prostate cancer. The extent of this phenomenon varies across different stages of prostate cancer development with more advanced tumours showing higher state of hypoxia. Here we review the current understanding of tumour hypoxia and its implications on treatment outcome including treatment with androgen ablation therapy. In particular, hypoxia selects for cells with geno-phenotypes for survival advantage and malignant progression in both experimental and clinical models of prostate cancer. Evidence showed that tumour hypoxia may serve as a potent therapeutic target in treatment of prostate cancer.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Medicine and Medical Sciences
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Maxwell Omabe”
- BylineArticles whose byline prints “Ewenighi Chinwe”
- BylineArticles whose byline prints “J.C Onyeanusi”
- BylineArticles whose byline prints “Nnatuanya I. N.”
- BylineArticles whose byline prints “Onoh L. U. M.”
- BylineArticles whose byline prints “Ezugwu Uchechukwu A.”
